Nephro Care India Limited

🔴 Bear CaseWhat could go wrong?

1. Margins are being competed away
   EBITDA margin has fallen from 21.2% to 12.6%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
2. Sales are being booked faster than collected
   Receivables are up 14356% against revenue up 396%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
3. Returns on shareholder capital are falling
   ROE has dropped from 79.7% to 5.9%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.
4. Size brings its own risk
   Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
5. Several serious flags at once
   3 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.